India, Jan. 27 -- The company has established itself as Asia's leading integrated healthcare services provider, with a strong footprint across the healthcare ecosystem, including hospitals, pharmacies, primary care and diagnostic clinics, and multiple retail health formats is now in the spotlight after Citi gave an upside target of 41 percent and expects 17 percent EBITDA CAGR by FY28.

With a market capitalisation of Rs. 97,915 cr, the shares of Apollo Hospitals Enterprise Ltd closed at Rs. 6,809.90 per share, up from its previous close of Rs. 6,797 per share.

The stock has delivered 162 percent returns over the past five years, 2 percent down over the last year, declined 8 percent in the past six months, and is down 4 percent over the ...